Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia

por Gimenes-Teixeira, Hamilton L, Lucena-Araujo, Antonio R, dos Santos, Guilherme A, Zanette, Dalila L, Scheucher, Priscila S, Oliveira, Luciana C, Dalmazzo, Leandro F, Silva-Júnior, Wilson A, Falcão, Roberto P, Rego, Eduardo M
Publicado 2013

Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model

por Assis, Patricia A., De Figueiredo-Pontes, Lorena L., Lima, Ana Silvia G., Leão, Vitor, Cândido, Larissa A., Pintão, Carolina T., Garcia, Aglair B., Saggioro, Fabiano P., Panepucci, Rodrigo A, Chahud, Fernando, Nagler, Arnon, Falcão, Roberto P., Rego, Eduardo M.
Publicado 2015

Halofuginone Has Anti-Proliferative Effects in Acute Promyelocytic Leukemia by Modulating the Transforming Growth Factor Beta Signaling Pathway

por de Figueiredo-Pontes, Lorena L., Assis, Patricia A., Santana-Lemos, Bárbara A. A., Jácomo, Rafael H., Lima, Ana Sílvia G., Garcia, Aglair B., Thomé, Carolina H., Araújo, Amélia G., Panepucci, Rodrigo A., Zago, Marco A., Nagler, Arnon, Falcão, Roberto P., Rego, Eduardo M.
Publicado 2011